奥曲肽治疗乙肝后肝硬化失代偿期顽固性腹水疗效观察
![]() |
第1页 |
参见附件。
【摘 要】目的:探讨奥曲肽治疗乙肝后肝硬化失代偿顽固性腹水的疗效。方法:46例患者随机分为2组,对照组给予纠正低蛋白血症、利尿、维持电解质平衡、抗病毒等常规治疗。治疗组在上述基础上加用 奥曲肽 0.1mg 皮下注射 tid 。结果:治疗组相比对照组尿量增加、腹水减少,体重减轻。治疗组总体有效率为82.61%,明显高于对照组56.52%的治疗有效率。结论:奥曲肽在治疗乙肝后肝硬化顽固性腹水效果显著。
【关键词】奥曲肽;乙肝后肝硬化;顽固性腹水
【中图分类号】R575.29 【文献标识码】A 【文章编号】1004-7484(2014)06-3527-01
【Abstract】Objective: To investigate octreotide treatment of decompensated liver cirrhosis with refractory ascites effect. Methods: 46 patients were randomly divided into two groups, a control group was given hypoproteinemia, diuretic, to maintain electrolyte balance, anti-virus and other conventional treatment. In the treatment group, based on the use of octreotide 0.1mg subcutaneous tid. Results: The treatment group compared to the control group to increase the amount of urine ......
您现在查看是摘要介绍页,详见PDF附件。